GLP-1RA and SGLT-1/2 inhibitor combination: a promising adjunctive strategy for Type 1 Diabetes.
Combination of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter Inhibitors in Type 1 Diabetes: Why, when and How? An Exploration of the Rationale and Clinical Scenarios for Combining These 2 Adjunctive Agents.
Abstract
Combining GLP-1RAs and SGLT-1/2 inhibitors offers a promising adjunctive strategy for Type 1 Diabetes, aiming to improve glycemic control and weight.